Integrated hypertension and HIV care

Intervention

1 paper2 findings

  • 1 lab in 1 country
  • Funder: HORIZON EUROPE Framework Programme
  • Human trial1

Outcomes

2

Blood pressure

downin humans1

1 study
  1. Integrated hypertension and HIV care decreases blood pressure in humans (70% achieved ≥10 mmHg reduction).

    “after 12 months, 70% of all participants had achieved at least 10 mmHg reduction in their BP”

    Human trialAdults with HIV and previously diagnosed hypertension in rural Uganda; intervention-arm comparison with baselinemulticomponent health services intervention12 months60% femalesn = 1,200

    Blood pressure control rose with combined care in Uganda

    Open Res Europe12 Oct 2026Preprint

Blood pressure control

upin humans1

1 study
  1. Integrated hypertension and HIV care increases blood pressure control in humans (Control increased from 3.6% to 36.7%; +33.1 percentage points (95% CI 25.3–41.0); p < 0.001).

    “After 12 months of the intervention, 36.7% had achieved control, corresponding to an absolute increase of 33.1% (95%CI: 25.3–41.0%; p < 0.001).”

    Human trialAdults with HIV and previously diagnosed hypertension in rural Uganda; intervention-arm comparison with baselinemulticomponent health services intervention12 months60% femalesn = 1,200

    Blood pressure control rose with combined care in Uganda

    Open Res Europe12 Oct 2026Preprint

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months
Open Res Europe

Blood pressure control rose with combined care in Uganda

Among adults with human immunodeficiency virus (HIV), blood pressure control rose from 3.6% at baseline to 36.7% after 12 months of combined care.Among adults with human immunodeficiency virus (HIV), blood pressure control rose from 3.6% at baseline to 36.7% after 12 months of combined care.

Preprint: randomised trial in 1,200 adults with HIV and hypertension, 12 monthsInterventions

Limit: Only intervention participants were analysed, without comparison against the trial’s control group